Literature DB >> 34221227

A Case of Minocycline-induced Linear Morphea Reactivation.

Cory Pettit1, Joy Mosser-Goldfarb1.   

Abstract

Morphea is a localized form of scleroderma that presents with dermal thickening and fibrotic plaques in the absence of internal organ involvement. Like many autoimmune conditions, these plaques have many different phases, starting out as active, red plaques before later burning out, leaving white, fibrotic plaques behind. Many drugs have been shown to induce morphea, including bleomycin and bromocriptine. We present a case of minocycline-induced reactivation of previously burned out morphea plaques. Minocycline is an important drug in dermatology and the reporting of new adverse events is important so as to help clinicians better weigh the risks and benefits of the drug for specific populations.
Copyright © 2021. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Fibrotic plaques; autoimmune; minocycline; morphea; scleroderma

Year:  2021        PMID: 34221227      PMCID: PMC8211344     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  11 in total

Review 1.  Tetracyclines: nonantibiotic properties and their clinical implications.

Authors:  Allen N Sapadin; Raul Fleischmajer
Journal:  J Am Acad Dermatol       Date:  2006-02       Impact factor: 11.527

Review 2.  Minocycline and autoimmunity.

Authors:  E V Hess
Journal:  Clin Exp Rheumatol       Date:  1998 Sep-Oct       Impact factor: 4.473

3.  Development of morphoea in rheumatoid arthritis treated with penicillamine.

Authors:  B J Liddle
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

Review 4.  Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.

Authors:  Nicole Fett; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2011-02       Impact factor: 11.527

5.  Sclerodermatous skin reaction after vitamin K1 injections.

Authors:  M S Guidetti; C Vincenzi; M Papi; A Tosti
Journal:  Contact Dermatitis       Date:  1994-07       Impact factor: 6.600

6.  Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts.

Authors:  L Mattila; K Airola; M Ahonen; M Hietarinta; C Black; U Saarialho-Kere; V M Kähäri
Journal:  J Invest Dermatol       Date:  1998-04       Impact factor: 8.551

7.  Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.

Authors:  Saori Tomimura; Fumihide Ogawa; Yohei Iwata; Kazuhiro Komura; Toshihide Hara; Eiji Muroi; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Shinichi Sato
Journal:  J Dermatol Sci       Date:  2008-06-18       Impact factor: 4.563

Review 8.  Drug-induced morphea: report of a case induced by balicatib and review of the literature.

Authors:  Anna Peroni; Antonio Zini; Vania Braga; Chiara Colato; Silvano Adami; Giampiero Girolomoni
Journal:  J Am Acad Dermatol       Date:  2008-04-14       Impact factor: 11.527

Review 9.  Pediatric morphea.

Authors:  John C Browning
Journal:  Dermatol Clin       Date:  2013-02-01       Impact factor: 3.478

10.  Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis.

Authors:  Lucille Desallais; Jérôme Avouac; Maxime Fréchet; Muriel Elhai; Rojo Ratsimandresy; Matthieu Montes; Hadley Mouhsine; Hervé Do; Jean-François Zagury; Yannick Allanore
Journal:  Arthritis Res Ther       Date:  2014-07-24       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.